ArticleThe Lancet. Rheumatology2022

Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.

Laura Boekel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.